3/1
06:03 am
RVNC
Rating for RVNC
Medium
Report
Rating for RVNC
3/1
06:03 am
RVNC
Rating for RVNC
Medium
Report
Rating for RVNC
3/1
06:03 am
RVNC
Rating for RVNC
Medium
Report
Rating for RVNC
2/29
03:42 pm
RVNC
Revance Therapeutics, Inc. (NASDAQ: RVNC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Low
Report
Revance Therapeutics, Inc. (NASDAQ: RVNC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
2/29
08:32 am
RVNC
Rating for RVNC
High
Report
Rating for RVNC
2/29
08:32 am
RVNC
Rating for RVNC
High
Report
Rating for RVNC
1/29
03:03 pm
RVNC
Rating for RVNC
Low
Report
Rating for RVNC
1/29
03:03 pm
RVNC
Rating for RVNC
Low
Report
Rating for RVNC
1/29
07:28 am
RVNC
Revance Therapeutics, Inc. (NASDAQ: RVNC) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating. They now have a $9.00 price target on the stock, down previously from $16.00.
Medium
Report
Revance Therapeutics, Inc. (NASDAQ: RVNC) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating. They now have a $9.00 price target on the stock, down previously from $16.00.
1/29
07:28 am
RVNC
Revance Therapeutics, Inc. (NASDAQ: RVNC) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating. They now have a $9.00 price target on the stock, down previously from $16.00.
Medium
Report
Revance Therapeutics, Inc. (NASDAQ: RVNC) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating. They now have a $9.00 price target on the stock, down previously from $16.00.
1/29
07:26 am
RVNC
Rating for RVNC
Medium
Report
Rating for RVNC
1/29
07:26 am
RVNC
Rating for RVNC
Medium
Report
Rating for RVNC